CN108059184B - Method for preparing ZnO nanoparticles by taking recombinant collagen as biomineralization template - Google Patents
Method for preparing ZnO nanoparticles by taking recombinant collagen as biomineralization template Download PDFInfo
- Publication number
- CN108059184B CN108059184B CN201711459404.7A CN201711459404A CN108059184B CN 108059184 B CN108059184 B CN 108059184B CN 201711459404 A CN201711459404 A CN 201711459404A CN 108059184 B CN108059184 B CN 108059184B
- Authority
- CN
- China
- Prior art keywords
- recombinant collagen
- preparing
- collagen
- zno
- biomineralization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000008186 Collagen Human genes 0.000 title claims abstract description 66
- 108010035532 Collagen Proteins 0.000 title claims abstract description 66
- 229920001436 collagen Polymers 0.000 title claims abstract description 66
- 238000000034 method Methods 0.000 title claims abstract description 33
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 24
- 230000033558 biomineral tissue development Effects 0.000 title claims abstract description 20
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 21
- 239000002086 nanomaterial Substances 0.000 claims abstract description 21
- XIOUDVJTOYVRTB-UHFFFAOYSA-N 1-(1-adamantyl)-3-aminothiourea Chemical compound C1C(C2)CC3CC2CC1(NC(=S)NN)C3 XIOUDVJTOYVRTB-UHFFFAOYSA-N 0.000 claims abstract description 12
- 238000001035 drying Methods 0.000 claims abstract description 10
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 10
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 10
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 10
- 239000011259 mixed solution Substances 0.000 claims abstract description 7
- 230000002194 synthesizing effect Effects 0.000 claims abstract description 7
- 239000007787 solid Substances 0.000 claims description 15
- 239000000243 solution Substances 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 230000001580 bacterial effect Effects 0.000 claims description 9
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 239000003242 anti bacterial agent Substances 0.000 claims description 6
- 229940088710 antibiotic agent Drugs 0.000 claims description 6
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 239000013612 plasmid Substances 0.000 claims description 6
- 239000012460 protein solution Substances 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 6
- 238000005119 centrifugation Methods 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 4
- 241000894006 Bacteria Species 0.000 claims description 3
- 235000019750 Crude protein Nutrition 0.000 claims description 3
- 241000588724 Escherichia coli Species 0.000 claims description 3
- 241001052560 Thallis Species 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 238000004925 denaturation Methods 0.000 claims description 3
- 230000036425 denaturation Effects 0.000 claims description 3
- 238000005516 engineering process Methods 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 239000001963 growth medium Substances 0.000 claims description 3
- 230000006698 induction Effects 0.000 claims description 3
- 238000004811 liquid chromatography Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 239000001488 sodium phosphate Substances 0.000 claims description 3
- 229910000162 sodium phosphate Inorganic materials 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000009210 therapy by ultrasound Methods 0.000 claims description 3
- 230000001131 transforming effect Effects 0.000 claims description 3
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 239000011701 zinc Substances 0.000 claims description 3
- 239000012880 LB liquid culture medium Substances 0.000 claims description 2
- 239000000975 dye Substances 0.000 abstract description 13
- 230000015556 catabolic process Effects 0.000 abstract description 6
- 238000006731 degradation reaction Methods 0.000 abstract description 6
- 239000002351 wastewater Substances 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 2
- 238000010353 genetic engineering Methods 0.000 abstract 1
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 86
- 239000011787 zinc oxide Substances 0.000 description 44
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 8
- 229940043267 rhodamine b Drugs 0.000 description 8
- 230000000694 effects Effects 0.000 description 6
- UIMCLYYSUCIUJM-UWVGGRQHSA-N Pro-Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 UIMCLYYSUCIUJM-UWVGGRQHSA-N 0.000 description 5
- 108010009111 arginyl-glycyl-glutamic acid Proteins 0.000 description 5
- DHDOADIPGZTAHT-YUMQZZPRSA-N Gly-Glu-Arg Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N DHDOADIPGZTAHT-YUMQZZPRSA-N 0.000 description 4
- LOEANKRDMMVOGZ-YUMQZZPRSA-N Gly-Lys-Asp Chemical compound NCCCC[C@H](NC(=O)CN)C(=O)N[C@@H](CC(O)=O)C(O)=O LOEANKRDMMVOGZ-YUMQZZPRSA-N 0.000 description 4
- AAORVPFVUIHEAB-YUMQZZPRSA-N Lys-Asp-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O AAORVPFVUIHEAB-YUMQZZPRSA-N 0.000 description 4
- 238000004833 X-ray photoelectron spectroscopy Methods 0.000 description 4
- 230000003197 catalytic effect Effects 0.000 description 4
- 108010078144 glutaminyl-glycine Proteins 0.000 description 4
- 238000002411 thermogravimetry Methods 0.000 description 4
- AUFHLLPVPSMEOG-YUMQZZPRSA-N Arg-Gly-Glu Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O AUFHLLPVPSMEOG-YUMQZZPRSA-N 0.000 description 3
- NSORZJXKUQFEKL-JGVFFNPUSA-N Gln-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CCC(=O)N)N)C(=O)O NSORZJXKUQFEKL-JGVFFNPUSA-N 0.000 description 3
- CAVKXZMMDNOZJU-UHFFFAOYSA-N Gly-Pro-Ala-Gly-Pro Natural products C1CCC(C(O)=O)N1C(=O)CNC(=O)C(C)NC(=O)C1CCCN1C(=O)CN CAVKXZMMDNOZJU-UHFFFAOYSA-N 0.000 description 3
- 108010047495 alanylglycine Proteins 0.000 description 3
- JYPCXBJRLBHWME-UHFFFAOYSA-N glycyl-L-prolyl-L-arginine Natural products NCC(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(O)=O JYPCXBJRLBHWME-UHFFFAOYSA-N 0.000 description 3
- HAFCJCDJGIOYPW-WDSKDSINSA-N Asp-Gly-Gln Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(N)=O HAFCJCDJGIOYPW-WDSKDSINSA-N 0.000 description 2
- PZXPWHFYZXTFBI-YUMQZZPRSA-N Asp-Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC(O)=O PZXPWHFYZXTFBI-YUMQZZPRSA-N 0.000 description 2
- WQWMZOIPXWSZNE-WDSKDSINSA-N Gln-Asp-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O WQWMZOIPXWSZNE-WDSKDSINSA-N 0.000 description 2
- MOJKRXIRAZPZLW-WDSKDSINSA-N Gly-Glu-Ala Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O MOJKRXIRAZPZLW-WDSKDSINSA-N 0.000 description 2
- HFXJIZNEXNIZIJ-BQBZGAKWSA-N Gly-Glu-Gln Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O HFXJIZNEXNIZIJ-BQBZGAKWSA-N 0.000 description 2
- UUYBFNKHOCJCHT-VHSXEESVSA-N Gly-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN UUYBFNKHOCJCHT-VHSXEESVSA-N 0.000 description 2
- JYPCXBJRLBHWME-IUCAKERBSA-N Gly-Pro-Arg Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O JYPCXBJRLBHWME-IUCAKERBSA-N 0.000 description 2
- OOCFXNOVSLSHAB-IUCAKERBSA-N Gly-Pro-Pro Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 OOCFXNOVSLSHAB-IUCAKERBSA-N 0.000 description 2
- GLACUWHUYFBSPJ-FJXKBIBVSA-N Gly-Pro-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CN GLACUWHUYFBSPJ-FJXKBIBVSA-N 0.000 description 2
- DPWGZWUMUUJQDT-IUCAKERBSA-N Leu-Gln-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O DPWGZWUMUUJQDT-IUCAKERBSA-N 0.000 description 2
- UCBPDSYUVAAHCD-UWVGGRQHSA-N Leu-Pro-Gly Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O UCBPDSYUVAAHCD-UWVGGRQHSA-N 0.000 description 2
- MSIYNSBKKVMGFO-BHNWBGBOSA-N Thr-Gly-Pro Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)N1CCC[C@@H]1C(=O)O)N)O MSIYNSBKKVMGFO-BHNWBGBOSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 108010047857 aspartylglycine Proteins 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 238000002447 crystallographic data Methods 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 238000002003 electron diffraction Methods 0.000 description 2
- 108010010147 glycylglutamine Proteins 0.000 description 2
- 108010050848 glycylleucine Proteins 0.000 description 2
- 108010015792 glycyllysine Proteins 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 239000011147 inorganic material Substances 0.000 description 2
- 108010057821 leucylproline Proteins 0.000 description 2
- 108010003700 lysyl aspartic acid Proteins 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 238000001782 photodegradation Methods 0.000 description 2
- 238000007639 printing Methods 0.000 description 2
- 108010014614 prolyl-glycyl-proline Proteins 0.000 description 2
- 108010029020 prolylglycine Proteins 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 108010061238 threonyl-glycine Proteins 0.000 description 2
- SUHLZMHFRALVSY-YUMQZZPRSA-N Ala-Lys-Gly Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)NCC(O)=O SUHLZMHFRALVSY-YUMQZZPRSA-N 0.000 description 1
- OLVIPTLKNSAYRJ-YUMQZZPRSA-N Asn-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)N OLVIPTLKNSAYRJ-YUMQZZPRSA-N 0.000 description 1
- QCVXMEHGFUMKCO-YUMQZZPRSA-N Asp-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC(O)=O QCVXMEHGFUMKCO-YUMQZZPRSA-N 0.000 description 1
- ZPDVKYLJTOFQJV-WDSKDSINSA-N Gln-Asn-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O ZPDVKYLJTOFQJV-WDSKDSINSA-N 0.000 description 1
- VSXBYIJUAXPAAL-WDSKDSINSA-N Gln-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CCC(N)=O VSXBYIJUAXPAAL-WDSKDSINSA-N 0.000 description 1
- MFJAPSYJQJCQDN-BQBZGAKWSA-N Gln-Gly-Glu Chemical compound NC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O MFJAPSYJQJCQDN-BQBZGAKWSA-N 0.000 description 1
- FGYPOQPQTUNESW-IUCAKERBSA-N Gln-Gly-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)N FGYPOQPQTUNESW-IUCAKERBSA-N 0.000 description 1
- SXGMGNZEHFORAV-IUCAKERBSA-N Gln-Lys-Gly Chemical compound C(CCN)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCC(=O)N)N SXGMGNZEHFORAV-IUCAKERBSA-N 0.000 description 1
- UTKUTMJSWKKHEM-WDSKDSINSA-N Glu-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O UTKUTMJSWKKHEM-WDSKDSINSA-N 0.000 description 1
- GPSHCSTUYOQPAI-JHEQGTHGSA-N Glu-Thr-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O GPSHCSTUYOQPAI-JHEQGTHGSA-N 0.000 description 1
- GZUKEVBTYNNUQF-WDSKDSINSA-N Gly-Ala-Gln Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O GZUKEVBTYNNUQF-WDSKDSINSA-N 0.000 description 1
- VXKCPBPQEKKERH-IUCAKERBSA-N Gly-Arg-Pro Chemical compound NC(N)=NCCC[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(O)=O VXKCPBPQEKKERH-IUCAKERBSA-N 0.000 description 1
- KKBWDNZXYLGJEY-UHFFFAOYSA-N Gly-Arg-Pro Natural products NCC(=O)NC(CCNC(=N)N)C(=O)N1CCCC1C(=O)O KKBWDNZXYLGJEY-UHFFFAOYSA-N 0.000 description 1
- BULIVUZUDBHKKZ-WDSKDSINSA-N Gly-Gln-Asn Chemical compound NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O BULIVUZUDBHKKZ-WDSKDSINSA-N 0.000 description 1
- PAWIVEIWWYGBAM-YUMQZZPRSA-N Gly-Leu-Ala Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O PAWIVEIWWYGBAM-YUMQZZPRSA-N 0.000 description 1
- TWTPDFFBLQEBOE-IUCAKERBSA-N Gly-Leu-Gln Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O TWTPDFFBLQEBOE-IUCAKERBSA-N 0.000 description 1
- CLNSYANKYVMZNM-UWVGGRQHSA-N Gly-Lys-Arg Chemical compound NCCCC[C@H](NC(=O)CN)C(=O)N[C@H](C(O)=O)CCCN=C(N)N CLNSYANKYVMZNM-UWVGGRQHSA-N 0.000 description 1
- FHQRLHFYVZAQHU-IUCAKERBSA-N Gly-Lys-Gln Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O FHQRLHFYVZAQHU-IUCAKERBSA-N 0.000 description 1
- IEGFSKKANYKBDU-QWHCGFSZSA-N Gly-Phe-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)CN)C(=O)O IEGFSKKANYKBDU-QWHCGFSZSA-N 0.000 description 1
- GGLIDLCEPDHEJO-BQBZGAKWSA-N Gly-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)CN GGLIDLCEPDHEJO-BQBZGAKWSA-N 0.000 description 1
- ABPRMMYHROQBLY-NKWVEPMBSA-N Gly-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)CN)C(=O)O ABPRMMYHROQBLY-NKWVEPMBSA-N 0.000 description 1
- 108010065920 Insulin Lispro Proteins 0.000 description 1
- XFIHDSBIPWEYJJ-YUMQZZPRSA-N Lys-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN XFIHDSBIPWEYJJ-YUMQZZPRSA-N 0.000 description 1
- GPJGFSFYBJGYRX-YUMQZZPRSA-N Lys-Gly-Asp Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O GPJGFSFYBJGYRX-YUMQZZPRSA-N 0.000 description 1
- LCMWVZLBCUVDAZ-IUCAKERBSA-N Lys-Gly-Glu Chemical compound [NH3+]CCCC[C@H]([NH3+])C(=O)NCC(=O)N[C@H](C([O-])=O)CCC([O-])=O LCMWVZLBCUVDAZ-IUCAKERBSA-N 0.000 description 1
- 244000141359 Malus pumila Species 0.000 description 1
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- BNBBNGZZKQUWCD-IUCAKERBSA-N Pro-Arg-Gly Chemical compound NC(N)=NCCC[C@@H](C(=O)NCC(O)=O)NC(=O)[C@@H]1CCCN1 BNBBNGZZKQUWCD-IUCAKERBSA-N 0.000 description 1
- AFXCXDQNRXTSBD-FJXKBIBVSA-N Pro-Gly-Thr Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O AFXCXDQNRXTSBD-FJXKBIBVSA-N 0.000 description 1
- DCHQYSOGURGJST-FJXKBIBVSA-N Pro-Thr-Gly Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O DCHQYSOGURGJST-FJXKBIBVSA-N 0.000 description 1
- VVZDBPBZHLQPPB-XVKPBYJWSA-N Val-Glu-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O VVZDBPBZHLQPPB-XVKPBYJWSA-N 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- 108010025801 glycyl-prolyl-arginine Proteins 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002159 nanocrystal Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 238000010525 oxidative degradation reaction Methods 0.000 description 1
- 239000002957 persistent organic pollutant Substances 0.000 description 1
- 230000001699 photocatalysis Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 108010077112 prolyl-proline Proteins 0.000 description 1
- 108010087846 prolyl-prolyl-glycine Proteins 0.000 description 1
- 108010004914 prolylarginine Proteins 0.000 description 1
- 108010053725 prolylvaline Proteins 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 238000003911 water pollution Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G9/00—Compounds of zinc
- C01G9/02—Oxides; Hydroxides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/70—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
- C01P2002/72—Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by d-values or two theta-values, e.g. as X-ray diagram
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/80—Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70
- C01P2002/85—Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70 by XPS, EDX or EDAX data
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2002/00—Crystal-structural characteristics
- C01P2002/80—Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70
- C01P2002/88—Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70 by thermal analysis data, e.g. TGA, DTA, DSC
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/01—Particle morphology depicted by an image
- C01P2004/03—Particle morphology depicted by an image obtained by SEM
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/01—Particle morphology depicted by an image
- C01P2004/04—Particle morphology depicted by an image obtained by TEM, STEM, STM or AFM
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Nanotechnology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Composite Materials (AREA)
- Inorganic Chemistry (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Toxicology (AREA)
- Plant Pathology (AREA)
- Materials Engineering (AREA)
- Microbiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Peptides Or Proteins (AREA)
Abstract
The invention discloses a method for preparing ZnO nanoparticles by taking recombinant collagen as a biomineralization template, which comprises the following steps: (1) preparing recombinant collagen by utilizing a biological genetic engineering technology: determining the sequence of recombinant collagen; synthesizing nucleic acid encoding recombinant collagen; preparing and purifying the recombinant collagen; (2) preparing a ZnO nano material: preparing a uniformly mixed solution of recombinant collagen, zinc nitrate hexahydrate and sodium hydroxide; secondly, placing the mixed solution in a thermostat at 25 ℃; purifying and drying the prepared nano material. The invention adopts recombinant collagen as a biological template and zinc nitrate hexahydrate as a raw material to prepare the ZnO nano material with controllable size and shape at room temperature. The method is simple and convenient, is easy to operate, and the prepared ZnO nano material has excellent degradation capability on various organic dyes and has great application prospect in treatment of dye wastewater.
Description
Technical Field
The invention belongs to the technical field of preparation of biological inorganic materials, and particularly relates to a method for preparing ZnO nanoparticles by taking recombinant collagen as a biomineralization template.
Background
With the rapid development of global economy, people pay attention to the protection of the environment and pay particular attention to the problem of water pollution. The printing and dyeing wastewater in China has the characteristics of large discharge amount, more substances difficult to degrade, complex organic matter components, deep chroma and the like, and an efficient treatment method is urgently needed to be developed. The organic dye is a main component of printing and dyeing wastewater, such as a representative cationic dye rhodamine B, which has strong fluorescence property in a solution, and even if the concentration is low, the light transmittance of a water body is reduced, so that the ecological environment is seriously damaged. At present, the treatment method of dye wastewater comprises coagulation method, biochemical method, flocculation method, electrochemical precipitation, photochemical catalytic oxidation, membrane separation method, adsorption method and the like. The photocatalytic oxidation method is a method for effectively oxidatively decomposing organic pollutants under light irradiation by utilizing the property that a semiconductor oxide material can be excited under light irradiation. Researches show that zinc oxide with different micro-morphologies prepared by different methods has different effects on oxidative degradation of organic dyes.
Biomineralization refers to the process of preparing inorganic mineral substances with specific morphology and functions by the regulation and control of biomacromolecules under mild physiological conditions. Different from industrial production conditions, the biomineralization general conditions are very mild, the energy consumption is low, and the pollution is less. Biomineralization thus provides a new strategy for the preparation of inorganic materials with unique structures and properties.
Disclosure of Invention
The invention aims to provide a method for preparing ZnO nanoparticles by taking recombinant collagen as a biomineralization template, aiming at the defects in the prior art.
In order to achieve the purpose, the invention discloses the following technical scheme:
a method for preparing ZnO nanoparticles by taking recombinant collagen as a biomineralization template comprises the following steps:
(1) preparation of recombinant collagen by biological gene engineering technology
Determining the sequence of the recombinant collagen:
the sequence of the recombinant collagen is as follows:
GSPGLPGPRGEQGPTGPTGPAGPRGLQGLQGLQGERGEQGPTGPAGPRGLQGERGEQGPTGLAGKAGEAGAKGETGPAGPQGPRGEQGPQGLPGKDGEAGAQGRPGKRGKQGQKGEKGEPGTQGAKGDRGETGPVGPRGERGEAGPAGKDGERGFPGERGVEGQNGQDGLPGKDGKDGQNGKDGLPGKDGKDGQNGKDGLPGKDGKDGQDGKDGLPGKDGKDGLPGKDGKDGQPGKPGKYGPPGPPGPPGPPGPPGPPGPPGPPGPPGPP, the recombinant collagen has good triple helix structure, and the temperature of thermal change is near 37 ℃;
② synthesizing nucleic acid encoding recombinant collagen:
synthesizing nucleic acid for encoding recombinant collagen in the step I, constructing a plasmid introduced into the nucleic acid, and transforming the plasmid into a escherichia coli BL21-DE3 strain;
preparing and purifying the recombinant collagen:
adding 50 μ L of bacterial liquid into 100mL LB liquid medium containing antibiotics, shaking overnight at constant temperature, culturing, transferring to 1Continuously carrying out amplification culture in an L LB culture medium containing antibiotics in a constant-temperature shaking table at 37 ℃; to be OD600Adjusting the temperature of a shaking table to 25 ℃ when the value reaches the range of 0.8-1, adding 1mM IPTG (isopropyl thiogalactoside) for induction expression, and culturing at constant temperature overnight; centrifuging the bacterial liquid in a low-temperature centrifuge, and collecting thalli; dissolving the bacteria with buffer A, wherein the buffer A is 20mM imidazole, 20mM sodium phosphate and 0.5M sodium chloride, and the pH value is 7.4; carrying out cell disruption by using an ultrasonic cell disruption instrument, and putting a bacterial suspension in an ice bath during ultrasonic treatment to prevent protein denaturation caused by overhigh temperature; and centrifuging the crushed suspension again to separate cell debris from the protein solution, wherein the centrifugation conditions are as follows: 14000rpm,4 ℃ and 30-50 min; collecting the supernatant, i.e. the crude protein solution, for further purification by liquid chromatography; then freeze-drying to obtain white flocculent solid; storing the solid in a refrigerator at-20 deg.C, and calibrating the concentration by weighing method;
(2) preparation of ZnO nano material
Preparing a uniformly mixed solution of recombinant collagen, zinc nitrate hexahydrate and sodium hydroxide:
adding 15-179mg of zinc nitrate hexahydrate and 0-20mg of collagen powder into 1mL of water, uniformly mixing, and slowly stirring for 5-120min to obtain colorless transparent uniform liquid; slowly dropwise adding a sodium hydroxide solution into the solution to obtain white floccules;
② preparing nano-ZnO under mild biomineralization condition:
placing the flocculent mixture in a thermostat at 20-37 deg.C for 1-40 days to obtain white precipitate;
purifying and drying the prepared nano material:
centrifuging the product under 12000rpm, and removing the supernatant to obtain solid; dispersing solid with deionized water, centrifuging for 3-5 times, and drying in a drying oven at constant temperature of 20-37 deg.C.
As a preferred technical scheme of the invention, the collagen powder in the step (2) is added in an amount of 0.1-5mg, and the mass fraction of the collagen is 0.01-0.5 wt%.
As a preferred technical scheme of the invention, the method comprises the following stepsThe solid zinc nitrate hexahydrate in the step (2) is added with the amount of 15-119mg, [ Zn ]2+]From 0.05 to 0.4 mol/L.
As a preferred technical scheme of the invention, the flocculent mixture in the second step of the step (2) is placed in a thermostat with the temperature of 25-37 ℃ for 1-10 days.
The invention has the beneficial effects that:
firstly, the research adopts recombinant collagen as a biological template and zinc nitrate hexahydrate as a raw material to prepare the ZnO nano material with controllable size and shape under mild conditions.
Secondly, the method does not need post-treatment in the whole synthesis process, is simple and convenient, is easy to operate, has a great application prospect, and can provide a foundation for large-scale production of the zinc oxide nano material.
Thirdly, the recombinant collagen is used as a biological template to regulate and control the zinc oxide nano crystal form to obtain the zinc oxide nano particles with specific shapes, and the zinc oxide nano particles have excellent photodegradation capability on organic dyes such as rhodamine B and the like.
Drawings
FIG. 1 is a powder X-ray polycrystalline diffraction (XRD) pattern of the prepared ZnO nanomaterial;
FIG. 2 is an X-ray photoelectron spectroscopy (XPS) chart of the prepared ZnO nanomaterial;
FIG. 3 is a thermogravimetric analysis (TGA) graph of the prepared ZnO nanomaterial;
FIG. 4 is a scanning electron microscope, transmission electron microscope, electron diffraction and energy scattering X-ray analysis chart of the prepared ZnO nano-material;
FIG. 5 is a graph showing the effect of different concentrations of recombinant collagen on the morphology of ZnO nanoparticles;
FIG. 6 is a graph showing the effect of nano ZnO on the catalytic degradation of rhodamine B at different ultraviolet irradiation times;
FIG. 7 shows the difference in the degradation capability of ZnO nanoparticles prepared using recombinant collagen of different concentrations as templates for rhodamine B;
Detailed Description
The technical solutions in the embodiments of the present invention will be described clearly and completely with reference to the drawings in the specification, and it is obvious that the described embodiments are only a part of the present invention, and not all of the invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1A method for preparing ZnO nanoparticles with recombinant collagen as biomineralization template
A method for preparing ZnO nanoparticles by using collagen as a biomineralization template comprises the following steps:
(1) preparation of recombinant collagen by biological gene engineering technology
Determining the sequence of the recombinant collagen:
the sequence of the recombinant collagen is as follows:
GSPGLPGPRGEQGPTGPTGPAGPRGLQGLQGLQGERGEQGPTGPAGPRGLQGERGEQGPTGLAGKAGEAGAKGETGPAGPQGPRGEQGPQGLPGKDGEAGAQGRPGKRGKQGQKGEKGEPGTQGAKGDRGETGPVGPRGERGEAGPAGKDGERGFPGERGVEGQNGQDGLPGKDGKDGQNGKDGLPGKDGKDGQNGKDGLPGKDGKDGQDGKDGLPGKDGKDGLPGKDGKDGQPGKPGKYGPPGPPGPPGPPGPPGPPGPPGPPGPPGPP, the recombinant collagen has good triple helix structure, and the temperature of thermal change is near 37 ℃;
② synthesizing nucleic acid encoding recombinant collagen:
synthesizing nucleic acid for encoding recombinant collagen in the step I, constructing a plasmid introduced into the nucleic acid, and transforming the plasmid into a escherichia coli BL21-DE3 strain;
preparing and purifying the recombinant collagen:
adding 50 mu L of bacterial liquid into 100mL of LB liquid culture medium containing antibiotics, carrying out enrichment culture by a constant temperature shaking table overnight, transferring to 1L of LB culture medium containing antibiotics, and continuing the enrichment culture in the constant temperature shaking table at 37 ℃; to be OD600Adjusting the temperature of a shaking table to 25 ℃ when the value reaches the range of 0.8-1, adding 1mM IPTG (isopropyl thiogalactoside) for induction expression, and culturing at constant temperature overnight; centrifuging the bacterial liquid in a low-temperature centrifuge, and collecting thalli; dissolving the bacteria with buffer A, wherein the buffer A is 20mM imidazole, 20mM sodium phosphate and 0.5M sodium chloride, and the pH value is 7.4;
carrying out cell disruption by using an ultrasonic cell disruption instrument, and putting a bacterial suspension in an ice bath during ultrasonic treatment to prevent protein denaturation caused by overhigh temperature; and centrifuging the crushed suspension again to separate cell debris from the protein solution, wherein the centrifugation conditions are as follows: 14000rpm,4 ℃ and 30-50 min; collecting the supernatant, i.e. the crude protein solution, for further purification by liquid chromatography; then freeze-drying to obtain white flocculent solid; storing the solid in a refrigerator at-20 deg.C, and calibrating the concentration by weighing method;
(2) preparation of ZnO nano material
Preparing a uniformly mixed solution of recombinant collagen, zinc nitrate hexahydrate and sodium hydroxide:
adding 15-179mg of zinc nitrate hexahydrate and 0-20mg of collagen powder into 1mL of water, uniformly mixing, and slowly stirring for 5-120min to obtain colorless transparent uniform liquid; slowly dropwise adding a sodium hydroxide solution into the solution to obtain white floccules;
② preparing nano-ZnO under mild biomineralization condition:
placing the flocculent mixture in a thermostat at 20-37 deg.C for 1-40 days to obtain white precipitate;
purifying and drying the prepared nano material:
centrifuging the product under 12000rpm, and removing the supernatant to obtain solid; dispersing solid with deionized water, centrifuging for 3-5 times, and drying in a drying oven at constant temperature of 20-37 deg.C.
Wherein the addition amount of the collagen powder in the step (2) is 1mg, and the mass fraction of the collagen is 0.1 wt%.
Wherein the addition amount of the zinc nitrate hexahydrate in the step (2) is 29.7mg, [ Zn ]2+]The concentration of (2) is 0.1 mol/L.
Wherein the flocculent mixture in the second step of the step (2) is placed in a thermostat with the temperature of 25 ℃ for 8 days.
Fig. 1 is a powder X-ray polycrystalline diffraction (XRD) pattern of the prepared ZnO nanomaterial, in which diffraction peaks correspond to diffraction data of ZnO. Fig. 2 is an X-ray photoelectron spectroscopy (XPS) graph of the prepared ZnO nanomaterial, in which diffraction peaks correspond to diffraction data of ZnO. FIG. 3 is a thermogravimetric analysis (TGA) chart of the prepared ZnO nanomaterial, and when the concentration of the added collagen is 0.01 wt%, the thermogravimetric loss is 2.2%; when the collagen concentration increased to 0.2 wt%, the thermogravimetric loss increased to 8.3%. These data indicate that we successfully prepared ZnO nanomaterials using collagen as a template. FIG. 4 is the scanning electron microscope and transmission of the prepared ZnO nano material
Analysis graphs of a radio-electron microscope, electron diffraction and energy scattering X rays show that the zinc oxide nanoparticles are uniform in shape and are apple-shaped, and collagen and ZnO are uniformly distributed in the apples; FIG. 5 is the effect of different concentrations of recombinant collagen on the morphology of ZnO nanoparticles. The concentration of the a-d collagen is 0.01 wt%, 0.05 wt%, 0.1 wt% and 0.2 wt% in sequence. The collagen can well regulate and control the morphology of the ZnO nanoparticles.
Example 2 experiment for degrading organic dye by using recombinant collagen as biomineralization template to prepare ZnO nanoparticles
1) Preparing a uniformly mixed solution of zinc oxide nanoparticles and an organic dye;
preparing 4-100mg/L organic dye solution, adding 2-10mg of the zinc oxide nanoparticles prepared in the example 1, and reacting for 10-120min in a dark place to ensure that the solution is balanced in absorption and analysis;
2) the zinc oxide nano particles degrade organic dye under the illumination condition;
irradiating the mixed solution with ultraviolet lamp for 0.5-48 hrs;
3) tracking the degradation level of the organic dye in different time periods by using an ultraviolet spectrophotometer;
analyzing the ultraviolet absorption conditions of the organic dye at different irradiation times by using an UV-1750 ultraviolet spectrophotometer;
as shown in fig. 6 (effect diagram of different time of catalytic degradation of rhodamine B by nano ZnO): after 3 hours of illumination, rhodamine B in the solution is completely decomposed.
As shown in fig. 7 (a graph comparing the degradation effect of nano ZnO with different morphologies on rhodamine B): the zinc oxide with different shapes has obvious difference on the photodegradation capability of rhodamine B, and the catalytic effect of the zinc oxide is obviously related to the shapes of the zinc oxide.
Sequence listing
<110> Lanzhou university
<120> method for preparing ZnO nanoparticles by taking recombinant collagen as biomineralization template
<160>1
<170>SIPOSequenceListing 1.0
<210>1
<211>270
<212>PRT
<213> Artificial Sequence (Artificial Sequence)
<400>1
Gly Ser Pro Gly Leu Pro Gly Pro Arg Gly Glu Gln Gly Pro Thr Gly
1 5 10 15
Pro Thr Gly Pro Ala Gly Pro Arg Gly Leu Gln Gly Leu Gln Gly Leu
20 25 30
Gln Gly Glu Arg Gly Glu Gln Gly Pro Thr Gly Pro Ala Gly Pro Arg
35 40 45
Gly Leu Gln Gly Glu Arg Gly Glu Gln Gly Pro Thr Gly Leu Ala Gly
50 55 60
Lys Ala Gly Glu Ala Gly Ala Lys Gly Glu Thr Gly Pro Ala Gly Pro
65 70 75 80
Gln Gly Pro Arg Gly Glu Gln Gly Pro Gln Gly Leu Pro Gly Lys Asp
85 90 95
Gly Glu Ala Gly Ala Gln Gly Arg Pro Gly Lys Arg Gly Lys Gln Gly
100 105 110
Gln Lys Gly Glu Lys Gly Glu Pro Gly Thr Gln Gly Ala Lys Gly Asp
115 120 125
Arg Gly Glu Thr Gly Pro Val Gly Pro Arg Gly Glu Arg Gly Glu Ala
130 135 140
Gly Pro Ala Gly Lys Asp Gly Glu Arg Gly Phe Pro Gly Glu Arg Gly
145 150 155 160
Val Glu Gly Gln Asn Gly Gln Asp Gly Leu Pro Gly Lys Asp Gly Lys
165 170 175
Asp Gly Gln Asn Gly Lys Asp Gly Leu Pro Gly Lys Asp Gly Lys Asp
180 185 190
Gly Gln Asn Gly Lys Asp Gly Leu Pro Gly Lys Asp Gly Lys Asp Gly
195 200 205
Gln Asp Gly Lys Asp Gly Leu Pro Gly Lys Asp Gly Lys Asp Gly Leu
210 215 220
Pro Gly Lys Asp Gly Lys Asp Gly Gln Pro Gly Lys Pro Gly Lys Tyr
225 230 235 240
Gly Pro Pro Gly Pro Pro Gly Pro Pro Gly Pro Pro Gly Pro Pro Gly
245 250 255
Pro Pro Gly Pro Pro Gly Pro Pro Gly Pro Pro Gly Pro Pro
260 265 270
Claims (4)
1. A method for preparing ZnO nanoparticles by taking recombinant collagen as a biomineralization template is characterized by comprising the following steps: the method comprises the following steps:
(1) preparation of recombinant collagen by biological gene engineering technology
(2) Preparation of ZnO nano material
Preparing a uniformly mixed solution of recombinant collagen, zinc nitrate hexahydrate and sodium hydroxide:
adding 15-179mg of zinc nitrate hexahydrate and collagen powder into 1ml of water, wherein the addition amount of the collagen powder is more than 0 and less than or equal to 20mg, uniformly mixing, and slowly stirring for 5-120min to obtain colorless, transparent and uniform liquid: slowly dropwise adding a sodium hydroxide solution into the solution to obtain white floccules;
② preparing nano-ZnO under mild biomineralization condition:
placing the flocculent mixture in a thermostat at 20-37 deg.C for 1-40 days to obtain white precipitate;
purifying and drying the prepared nano material:
the product was separated by centrifugation at 12000rpm, and the supernatant was discarded, leaving a solid: dispersing solid with deionized water, centrifuging and purifying for 3-5 times, and drying in a constant temperature drying oven at 20-37 deg.C;
the recombinant collagen in the step (1) is prepared by the following steps:
determining the sequence of the recombinant collagen:
the sequence of the recombinant collagen is as follows:
GSPGLPGPRGEQGPTGPTGPAGPRGLQGLQGLQGERGEQGPTGPAGPRGLQGERGEQGPTGLAGKAGEAGAKGETGPAGPQGPRGEQGPQGLPGKDGEAGAQGRPGKRGKQGQKGEKGEPGTQGAKGDRGETGPVGPRGERGEAGPAGKDGERGFPGERGVEGQNGQDGLPGKDGKDGQNGKDGLPGKDGKDGQNGKDGLPGKDGKDGQDGKDGLPGKDGKDGLPGKDGKDGQPGKPGKYGPPGPPGPPGPPGPPGPPGPPGPPGPPGPP, the recombinant collagen has good triple helix structure, and the temperature of thermal change is near 37 ℃;
② synthesizing nucleic acid encoding recombinant collagen:
synthesizing nucleic acid for coding the recombinant collagen in the first step in the step (1), constructing a plasmid introduced with the nucleic acid, and transforming the plasmid into escherichia coli BL21-DE 3;
preparing and purifying the recombinant collagen:
adding 50 mu L of bacterial liquid into 100mL of LB liquid culture medium containing antibiotics, carrying out enrichment culture by a constant temperature shaking table overnight, transferring to 1L of LB culture medium containing antibiotics, and continuing the enrichment culture in the constant temperature shaking table at 37 ℃; adjusting the temperature of the shaking table to 25 ℃ when the OD 600 value reaches the range of 0.8-1, adding 1mM IPTG (isopropyl thiogalactoside) for induction expression, and culturing at constant temperature overnight; centrifuging the bacterial liquid in a low-temperature centrifuge, and collecting thalli; dissolving the bacteria with buffer A, wherein the buffer A is 20mM imidazole, 20mM sodium phosphate and 0.5M sodium chloride, and the pH value is 7.4; carrying out cell disruption by using an ultrasonic cell disruption instrument, and putting a bacterial suspension in an ice bath during ultrasonic treatment to prevent protein denaturation caused by overhigh temperature; and centrifuging the crushed suspension again to separate cell debris from the protein solution, wherein the centrifugation conditions are as follows: 14000rpm,4 ℃ and 30-50 min; collecting the supernatant, i.e. the crude protein solution, for further purification by liquid chromatography; then freeze-drying to obtain white flocculent solid; the solid is stored in a refrigerator at the temperature of minus 20 ℃, and the concentration is calibrated by a weighing method when the solid is used.
2. The method for preparing ZnO nanoparticles by using the recombinant collagen as the biomineralization template as the claimed claim 1, wherein the method comprises the following steps: the addition amount of the collagen powder in the step (2) is 0.1-5mg, and the mass fraction of the collagen is 0.01-0.5 wt%.
3. The method for preparing ZnO nanoparticles by using the recombinant collagen as the biomineralization template as the claimed claim 1, wherein the method comprises the following steps: the solid zinc nitrate hexahydrate in the step (2) is added with the amount of 15-119mg, [ Zn ]2+]From 0.05 to 0.4 mol/L.
4. The method for preparing ZnO nanoparticles by using the recombinant collagen as the biomineralization template as the claimed claim 1, wherein the method comprises the following steps: placing the flocculent mixture in the second step in the step (2) in a thermostat with the temperature of 25-37 ℃ for 1-10 days.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711459404.7A CN108059184B (en) | 2017-12-28 | 2017-12-28 | Method for preparing ZnO nanoparticles by taking recombinant collagen as biomineralization template |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711459404.7A CN108059184B (en) | 2017-12-28 | 2017-12-28 | Method for preparing ZnO nanoparticles by taking recombinant collagen as biomineralization template |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108059184A CN108059184A (en) | 2018-05-22 |
CN108059184B true CN108059184B (en) | 2020-10-27 |
Family
ID=62140578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711459404.7A Active CN108059184B (en) | 2017-12-28 | 2017-12-28 | Method for preparing ZnO nanoparticles by taking recombinant collagen as biomineralization template |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108059184B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113520899B (en) * | 2021-03-25 | 2022-05-17 | 胶原蛋白(武汉)生物科技有限公司 | Recombinant collagen product for skin photodamage repair |
CN115521373B (en) * | 2022-06-06 | 2024-04-19 | 胶原蛋白(武汉)生物科技有限公司 | Triple helix recombinant humanized type I collagen, preparation method and application thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104071827A (en) * | 2014-07-22 | 2014-10-01 | 天津工业大学 | Method for synthesizing ordered laminar nanometer zinc oxide by using sodium dodecyl sulfate as template |
CN105797703A (en) * | 2016-04-18 | 2016-07-27 | 常州达奥新材料科技有限公司 | Method for preparing zinc oxide photocatalyst with peanut meal protein as biological template |
CN106115792A (en) * | 2016-06-23 | 2016-11-16 | 兰州大学 | One prepares Fe with collagen protein for biomineralization template2o3the method of nanoparticle |
CN106186046A (en) * | 2016-08-04 | 2016-12-07 | 苏州德捷膜材料科技有限公司 | A kind of preparation method of low cost one-dimension zinc oxide nano-powder |
CN106517302A (en) * | 2016-10-29 | 2017-03-22 | 乐山凯亚达光电科技有限公司 | Preparation method of nanoscale zinc oxide crystals |
CN107089677A (en) * | 2017-06-07 | 2017-08-25 | 首都医科大学宣武医院 | Preparation method of zinc oxide nanoparticles based on silk fibroin biological template regulation |
-
2017
- 2017-12-28 CN CN201711459404.7A patent/CN108059184B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104071827A (en) * | 2014-07-22 | 2014-10-01 | 天津工业大学 | Method for synthesizing ordered laminar nanometer zinc oxide by using sodium dodecyl sulfate as template |
CN105797703A (en) * | 2016-04-18 | 2016-07-27 | 常州达奥新材料科技有限公司 | Method for preparing zinc oxide photocatalyst with peanut meal protein as biological template |
CN106115792A (en) * | 2016-06-23 | 2016-11-16 | 兰州大学 | One prepares Fe with collagen protein for biomineralization template2o3the method of nanoparticle |
CN106186046A (en) * | 2016-08-04 | 2016-12-07 | 苏州德捷膜材料科技有限公司 | A kind of preparation method of low cost one-dimension zinc oxide nano-powder |
CN106517302A (en) * | 2016-10-29 | 2017-03-22 | 乐山凯亚达光电科技有限公司 | Preparation method of nanoscale zinc oxide crystals |
CN107089677A (en) * | 2017-06-07 | 2017-08-25 | 首都医科大学宣武医院 | Preparation method of zinc oxide nanoparticles based on silk fibroin biological template regulation |
Also Published As
Publication number | Publication date |
---|---|
CN108059184A (en) | 2018-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sathiyavimal et al. | Facile synthesis and characterization of hydroxyapatite from fish bones: Photocatalytic degradation of industrial dyes (crystal violet and Congo red) | |
CN106115792B (en) | One kind preparing Fe by biomineralization template of collagen2O3The method of nano-particle | |
Malarkodi et al. | Biosynthesis of semiconductor nanoparticles by using sulfur reducing bacteria Serratia nematodiphila | |
CN108059184B (en) | Method for preparing ZnO nanoparticles by taking recombinant collagen as biomineralization template | |
JP2007523096A (en) | Metal complex solution and its application | |
CN108126718B (en) | In2S3/BiPO4Preparation method and application of heterojunction photocatalyst | |
Rafique et al. | Dye degradation, antibacterial activity and molecular docking analysis of cellulose/polyvinylpyrrolidone-doped cadmium sulphide quantum dots | |
Shang et al. | Poultry eggshell-derived antimicrobial materials: Current status and future perspectives | |
Abbas et al. | Immobilized biogenic zinc oxide nanoparticles as photocatalysts for degradation of methylene blue dye and treatment of textile effluents | |
Abarna et al. | Influence of jute template on the surface, optical and photocatalytic properties of sol-gel derived mesoporous zinc oxide | |
El-Yazeed et al. | Fabrication and characterization of reduced graphene-BiVO4 nanocomposites for enhancing visible light photocatalytic and antibacterial activity | |
CN108383147B (en) | Method for preparing CuO nano particles by taking recombinant collagen as biomineralization template | |
Mpala et al. | Cellulose nanocrystal-mediated synthesis of silver nanoparticles via microwave assisted method for biofouling control in membrane distillation | |
Sinha et al. | Green approach to synthesize MnxZn1-xO nanocomposite with enhanced photocatalytic, fluorescence and antibacterial activity | |
CN113332971A (en) | Nano ZnO/g-C3N4Application of composite catalyst as algae inhibitor and preparation method thereof | |
Christwardana et al. | Effect of NaOH concentration as activator on calcined eggshell and its application for yeast microbial fuel cell | |
Bao et al. | Synthesis and antibacterial activities of Ag-TiO2/ZIF-8 | |
CN115708893A (en) | Manganese-doped hydroxyapatite nanowire bioceramic, preparation method and application | |
CN110433789A (en) | A method of photocatalysis biology carbon composite is prepared using Eichhornia crassipes accumulation nano zine oxide | |
CN111905748B (en) | Hollow columnar ZnFe 2 O 4 /CaTiO 3 Composite material and preparation and application thereof | |
Aba Guevara et al. | Water Disinfection Using Chitosan Microbeads With N-, C-, CN/TiO2 By Photocatalysis Under Visible Light | |
CN113955818A (en) | Preparation method of composite polyaluminum ferric chloride water treatment agent | |
Stoyanova et al. | Nonhydrolytic sol-gel synthesis and antibacterial properties of nanosized TiO2 | |
CN109735576B (en) | Method for preparing nano metal oxide by using bacterial supernatant, product and application thereof | |
Mousa et al. | Mangrove leaves aqueous extract mediated green synthesis of C-doped TiO2 nanoparticles and their ecotoxic effect on rotifers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201119 Address after: 730030 No.888 Yanchang Road Street, Chengguan District, Lanzhou City, Gansu Province Patentee after: Lanzhou Biological Technology Development Co.,Ltd. Address before: 730000 Gansu Province Chengguan District of Lanzhou city of Tianshui Road No. 222 Patentee before: LANZHOU University |
|
TR01 | Transfer of patent right |